Delivery Order SPE2DB24D2106-SPE2DB25FAVXJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,027.13 to DMS Pharmaceutical Group Inc. for Lisdexamfetamine 70 mg capsules (90-count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance at DMS Pharmaceutical Group's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on July 24, 2025, for Lisdexamfetamine 30 mg capsules (90-count units) with a ceiling value of $1,191.06. This firm fixed-price delivery order represents a specific pharmaceutical supply requirement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at $499,999,999 and valid through November 2026. The place of performance is Conshohocken, Pennsylvania. DMS Pharmaceutical Group...
- This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order valued at $1,176.64 for the supply of 4567764395 Lisdexamfetamine 50 mg capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of April 2, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,281.36 firm fixed-price contract is for the delivery of 100 units of the prescription drug lisdexamfetamine 70 mg capsules. The contract has a completion date of July 9, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,135.88 award is for the delivery of 100 units of 30mg lisdexamfetamine capsules. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to issue delivery orders for a wide range of pharmaceutical products,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,000.98 contract is for the delivery of 4,567,329,296 lisdexamfetamine 20 mg capsules, and has an ultimate completion date of February 21, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,070.16, is for the delivery of 4,567,197,276 units of the prescription drug Lisdexamfetamine 20 mg capsules. The award has a completion date of February 7, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,367.72, is for the delivery of 4,567,997,741 units of the prescription drug lisdexamfetamine 20 mg capsules. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue delivery...
- This is a $1,272.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 100 units of 60 mg lisdexamfetamine capsules. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,724.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Vyvanse 70 mg capsules to support the recurring medical supply needs of military health facilities. This delivery order falls under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAVXJDelivery Order
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 4, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100. This firm fixed-price delivery order, valued at $1,388.47, is set to be completed by August 5, 2025, with performance taking place in Conshohocken, Pennsylvania. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on equal footing despite its status as a small business. This delivery order represents a discrete pharmaceutical procurement issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. DMS Pharmaceutical Group, based in Park Ridge, Illinois, holds a significant single-award IDC with the Defense Logistics Agency valued at approximately $500 million through November 2026 under the SPE2DB program. This umbrella contract enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables supporting military health facilities worldwide. As a primary pharmaceutical supplier to the federal healthcare system, DMS Pharmaceutical Group has demonstrated consistent capability in delivering controlled and non-controlled pharmaceutical products to Department of Defense medical facilities across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/4/25 |